About me
Dr. Jason Awe serves as Head of Corporate Communications and Investor Relations at Adverum Biotechnologies, where he focuses on enterprise communication strategies and building Adverum's presence and relationships with the analyst and investor community in support of advancing the development of functional cures through gene therapy to restore vision and prevent blindness. With significant academic research experience in stem cell technology, molecular biology, and immunology, he has a strong ability to interpret complex scientific content to craft understandable and impactful communications that resonate with various stakeholders including the investment community. Prior to Adverum, Dr. Awe was at Atara Biotherapeutics and Amgen in a variety of diverse roles across investor relations, corporate communications, medical, value and access, and policy communications spanning oncology, hematology, and inflammation. He received his undergraduate degree in Pharmacology from the University of California, Santa Barbara, PhD in Molecular and Medical Pharmacology from UCLA, and MBA from UCLA Anderson School of Management.
